Literature DB >> 8105309

Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy.

M V Raynolds1, M R Bristow, E W Bush, W T Abraham, B D Lowes, L S Zisman, C S Taft, M B Perryman.   

Abstract

Polymorphism in the angiotensin-converting enzyme (ACE) gene has been shown to correlate with circulating ACE concentrations, and also to be an independent risk factor for the development of myocardial infarction, particularly in men thought to be at low risk by standard criteria. We determined the genotypes of individuals with end-stage heart failure due to either ischaemic dilated cardiomyopathy (102) or idiopathic dilated cardiomyopathy (112) and compared these to organ donors with normally functioning hearts (79). Genotypes were determined by the polymerase chain reaction with oligonucleotide primers flanking the polymorphic region in intron 16 of the ACE gene to amplify template DNA isolated from patients. Compared with the DD frequency in the control population, the frequency of the ACE DD genotype was 48% higher in individuals with idiopathic dilated cardiomyopathy (p = 0.008) and 63% higher in subjects with ischaemic cardiomyopathy (p = 0.008), suggesting that an ACE gene variant may contribute to the pathogenesis of both types of cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8105309     DOI: 10.1016/0140-6736(93)92061-w

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  70 in total

1.  Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries.

Authors:  M Hamon; C Amant; C Bauters; F Richard; N Helbecque; E McFadden; J M Lablanche; M Bertrand; P Amouyel
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

2.  Genotypes and allele frequencies of angiotensin-converting enzyme (ACE) insertion/deletion polymorphism among Bahraini population with type 2 diabetes mellitus and related diseases.

Authors:  Einas M Al-Harbi; Eman M Farid; Khalid A Gumaa; Jaipaul Singh
Journal:  Mol Cell Biochem       Date:  2011-11-13       Impact factor: 3.396

3.  RAAS and adrenergic genes in heart failure: Function, predisposition and survival implications.

Authors:  Alberto J Alves; Nir Eynon; José Oliveira; Ehud Goldhammer
Journal:  World J Cardiol       Date:  2010-07-26

4.  Association between ACE and AGT polymorphism and cardiovascular risk in acromegalic patients.

Authors:  Tomris Erbas; Nese Cinar; Selcuk Dagdelen; Arzu Gedik; Hikmet Yorgun; Ugur Canpolat; Giray Kabakci; Mehmet Alikasifoglu
Journal:  Pituitary       Date:  2017-10       Impact factor: 4.107

5.  Association of angiotensin-converting enzyme I/D polymorphism with heart failure: a meta-analysis.

Authors:  Yuanyuan Bai; Liang Wang; Shengshou Hu; Yingjie Wei
Journal:  Mol Cell Biochem       Date:  2011-10-21       Impact factor: 3.396

6.  The angiotensin converting enzyme gene in cardiovascular disease.

Authors:  M Caulfield; J Newell-Price
Journal:  Br Heart J       Date:  1995-09

7.  Is the inherited ACE genotype a trump or a joker?

Authors:  W E Mitch
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

Review 8.  [The renin-angiotensin system in cardiovascular diseases].

Authors:  C Unterberg; H Kreuzer; A B Buchwald
Journal:  Med Klin (Munich)       Date:  1998-07-15

9.  Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy.

Authors:  H Yoshida; T Mitarai; T Kawamura; T Kitajima; Y Miyazaki; R Nagasawa; Y Kawaguchi; H Kubo; I Ichikawa; O Sakai
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

10.  ACE gene polymorphism and cardiac structure in patients with insulin resistance.

Authors:  Fulya Akin; Sebahat Turgut; Dursun Dursunoglu; Gunfer Turgut; Ugur Karasu; Sukru Gur
Journal:  Mol Biol Rep       Date:  2008-03-18       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.